{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T02:14:22Z","timestamp":1758420862693,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.lfs.2023.121689","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T02:06:42Z","timestamp":1681178802000},"page":"121689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cloning, expression and in vitro validation of chimeric multi epitope vaccine candidate against visceral leishmaniasis infection"],"prefix":"10.1016","volume":"323","author":[{"given":"Rupal","family":"Ojha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailash","family":"Chand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.121689_bb0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apjtm.2016.06.021","article-title":"Worldwide risk factors in Leishmaniasis","volume":"9","author":"Oryan","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.lfs.2023.121689_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/857143","article-title":"The role of dendritic cells in tissue-specific autoimmunity","volume":"2014","author":"Mbongue","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.lfs.2023.121689_bb0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2023.121689_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.humimm.2009.01.007","article-title":"Th1\/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production","volume":"70","author":"Castellano","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.lfs.2023.121689_bb0025","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.121689_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/892817","article-title":"Development of vaccines against visceral leishmaniasis","volume":"2012","author":"Evans","year":"2012","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.lfs.2023.121689_bb0035","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J. Med. Res."},{"issue":"Suppl 1","key":"10.1016\/j.lfs.2023.121689_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00034983.1995.11813015","article-title":"Experimental models for leishmaniasis and for testing anti-Leishmanial vaccines","volume":"89","author":"Hommel","year":"1995","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.lfs.2023.121689_bb0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41541-020-00224-0","article-title":"A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection","volume":"5","author":"Lage","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.lfs.2023.121689_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8845826","article-title":"A chimera of Th1 stimulatory proteins ofLeishmania donovanioffers moderate immunotherapeutic efficacy with a Th1-inclined immune response against visceral leishmaniasis","volume":"2021","author":"Ratnapriya","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2023.121689_bb0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijbiomac.2020.04.097","article-title":"Vaccinomics strategy to concoct a promising subunit vaccine for visceral leishmaniasis targeting sandfly and Leishmania antigens","volume":"156","author":"Ojha","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2023.121689_bb0060","series-title":"Leishmania donovani: Identification of Stimulatory Soluble Antigenic Proteins Using Cured Human and Hamster Lymphocytes for Their Prophylactic Potential Against Visceral Leishmaniasis","first-page":"2900","volume":"24","author":"Garg","year":"2006"},{"key":"10.1016\/j.lfs.2023.121689_bb0065","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.323","article-title":"Isolation of human PBMCs","volume":"3","author":"Panda","year":"2013","journal-title":"Bio-protocol"},{"key":"10.1016\/j.lfs.2023.121689_bb0070","article-title":"Expression of recombinant proteins in the methylotrophic yeast Pichia pastoris","volume":"36","author":"Weidner","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.lfs.2023.121689_bb0075","series-title":"Condensed Protocol for Competent Cell Preparation and Transformation of the Methylotrophic Yeast Pichia pastoris","first-page":"44","volume":"38","author":"Lin-Cereghino","year":"2005"},{"key":"10.1016\/j.lfs.2023.121689_bb0080","series-title":"Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris","volume":"e1862","author":"Weidner","year":"2010"},{"key":"10.1016\/j.lfs.2023.121689_bb0085","series-title":"Medicine. A General Test for Carbohydrates","first-page":"830","volume":"27","author":"Levine","year":"1930"},{"key":"10.1016\/j.lfs.2023.121689_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0001-2018","article-title":"Function and biogenesis of lipopolysaccharides","volume":"8","author":"Bertani","year":"2018","journal-title":"EcoSal Plus"},{"key":"10.1016\/j.lfs.2023.121689_bb0095","first-page":"388","article-title":"Methods of endotoxin removal from biological preparations: a review","volume":"10","author":"Magalh\u00e3es","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.lfs.2023.121689_bb0100","series-title":"Cancer Cell Culture","first-page":"237","article-title":"Cell sensitivity assays: the MTT assay","author":"Van Meerloo","year":"2011"},{"key":"10.1016\/j.lfs.2023.121689_bb0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/iai.26.1.375-379.1979","article-title":"Multiplication of Leishmania in human macrophages in vitro","volume":"26","author":"Berman","year":"1979","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2023.121689_bb0110","series-title":"Isolation and Subfractionation of Human Peripheral Blood Mononuclear Cells (PBMC) by Density Gradient Centrifugation on Percoll","first-page":"238","volume":"166","author":"Ulmer","year":"1984"},{"key":"10.1016\/j.lfs.2023.121689_bb0115","series-title":"Combined Diagnostic Methods Identify a Remarkable Proportion of Asymptomatic Leishmania (Leishmania) Chagasi Carriers Who Present Modulated Cytokine Profiles","first-page":"548","volume":"102","author":"de Gouv\u00eaa","year":"2008"},{"key":"10.1016\/j.lfs.2023.121689_bb0120","series-title":"Protter: interactive protein feature visualization and integration with experimental proteomic data","first-page":"884","volume":"30","author":"Omasits","year":"2014"},{"key":"10.1016\/j.lfs.2023.121689_bb0125","series-title":"Pre-clinical Antigenicity Studies of an Innovative Multivalent Vaccine for Human Visceral Leishmaniasis","first-page":"e0005951","volume":"11","author":"Cec\u00edlio","year":"2017"},{"key":"10.1016\/j.lfs.2023.121689_bb0130","series-title":"From Mouse to Man: Safety, Immunogenicity and Efficacy of a Candidate Leishmaniasis Vaccine LEISH-F3+ GLA-SE","first-page":"e35","volume":"4","author":"Coler","year":"2015"},{"key":"10.1016\/j.lfs.2023.121689_bb0135","series-title":"A Defined Subunit Vaccine That Protects Against Vector-borne Visceral Leishmaniasis","first-page":"1","volume":"2","author":"Duthie","year":"2017"},{"key":"10.1016\/j.lfs.2023.121689_bb0140","series-title":"KSAC, the First Defined Polyprotein Vaccine Candidate for Visceral Leishmaniasis","first-page":"1118","volume":"18","author":"Goto","year":"2011"},{"key":"10.1016\/j.lfs.2023.121689_bb0145","series-title":"Evaluation of an Immunochemotherapeutic Protocol Constituted of N-methyl Meglumine Antimoniate (Glucantime\u00ae) and the Recombinant Leish-110f\u00ae+ MPL-SE\u00ae Vaccine to Treat Canine Visceral Leishmaniasis","first-page":"1585","volume":"26","author":"Miret","year":"2008"},{"key":"10.1016\/j.lfs.2023.121689_bb0150","series-title":"A Clinical Trial to Evaluate the Safety and Immunogenicity of the LEISH-F1+ MPL-SE Vaccine for Use in the Prevention of Visceral Leishmaniasis","first-page":"3531","volume":"29","author":"Chakravarty","year":"2011"},{"key":"10.1016\/j.lfs.2023.121689_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pep.2010.04.004","article-title":"Expression, purification, and characterization of recombinant human pancreatic duodenal homeobox-1 protein in Pichia pastoris","volume":"72","author":"Li","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.lfs.2023.121689_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12929-019-0591-0","article-title":"Synthetic carbohydrate-based vaccines: challenges and opportunities","volume":"27","author":"Mettu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2023.121689_bb0165","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1590\/S0100-879X2012007500142","article-title":"Recombinant vaccines and the development of new vaccine strategies","volume":"45","author":"Nascimento","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.lfs.2023.121689_bb0170","series-title":"Cognizance of Posttranslational Modifications in Vaccines: A Way to Enhanced Immunogenicity","first-page":"8020","volume":"236","author":"Ojha","year":"2021"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:10:58Z","timestamp":1758402658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":34,"alternative-id":["S0024320523003235"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121689","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cloning, expression and in vitro validation of chimeric multi epitope vaccine candidate against visceral leishmaniasis infection","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121689"}}